July 17th 2024
A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
ATP supplementation may mitigate post-exercise cognitive dysfunction, says recent study
August 30th 2023The researchers concluded that because supplements helped maintain proactive reaction time and improve reaction time after high intensity exercise, the results suggest that ATP may mitigate exercise-induced cognitive dysfunction.
Aker BioMarine announces successful NDIN for its Lysoveta ingredient
August 16th 2023Aker BioMarine has announced that its brain health ingredient, Lysoveta, has received an acknowledgement letter from the U.S. Food and Drug Administration (FDA) following its new dietary ingredient notification (NDIN).
All About Lecithin: What makes lecithin a powerhouse ingredient in food, drinks, and supplements?
July 17th 2023Lecithin is widely used in animal feed, nutritional supplements, and infant nutrition because, on top of exhibiting excellent functional properties, it provides great nutritional benefits.
New COSMOS ancillary study finds that multivitamin supplementation may support episodic memory
May 30th 2023The study included 3562 adults who were randomized to receive a daily multivitamins or placebo for three years while being evaluated annually with an internet-based battery of neuropsychological tests.